Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
NCT Number: NCT03335475
This study will adapt a physical activity lifestyle intervention to adolescent and emerging adult congenital heart disease (CHD) survivors with the primary goal of increasing physical activity levels.
The study will be split into 2 phases. In Phase 1, participants will be asked to complete questionnaires, wear an accelerometer around the waist for 7 days, and undergo an exercise stress test. The accelerometer and exercise stress test will be used to determine whether participants are eligible to be randomized for the intervention study. For adolescent participants, a parent will be asked to complete questionnaires at baseline as well. In Phase 2, participants will be randomized to one of two conditions: 1) receiving a physical activity tracker (a Fitbit) or 2) receiving a Fitbit AND engaging in videoconferencing sessions with a physical activity coach. During Phase 2, participants will also be asked to complete 3 assessments (weeks 9 and 22, and a 6-month follow-up). The week 9 assessment will consist of completing questionnaires and wearing an accelerometer for 7 days. Week 22 will be similar to week 9 with the addition of a final exercise stress test. The 6-month follow-up will mirror the week 9 assessment. For adolescent participants, the same parent will be asked to complete questionnaires at the final assessment as well.
Participants who are randomized to the videoconferencing condition will be asked to meet with a physical activity coach 8 times over the course of 20 weeks. Coaches will help participants to (1) change attitudes toward physical activity, (2) increase perception of others' approval of physical activity (e.g., family members, peers), and (3) increase participants' perceived control by troubleshooting barriers and increasing efficacy for physical activity. Coaches will use the Fitbit to facilitate self-monitoring and goal setting. Participants in the intervention arm will be asked to participate in a focus group at the conclusion of the study to share their experiences.
Looking for future studies?
Notify Me15 year–18 year
All sexes
Interventional
Not applicable
Columbus, Ohio, 43205, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Coaches work with participants on three elements of behaviors change: (1) changing attitudes towards physical activity; (2) increase perceptions of other people's approval of physical activity for the participants; (3) increase perceptions of control over being physically active. These elements will be delivered using a non-judgmental stance accompanied by promoting appropriate goal-setting.
A physical activity monitor (Fitbit) will be provided to both groups.
Other names: Fitbit
Time frame: From baseline to follow-up (approximately 22 weeks).
Baseline to follow-up change in number of minutes spent in moderate to vigorous physical activity as measured by an accelerometer
Time frame: From baseline to follow-up (approximately 22 weeks).
Baseline to follow-up change in number of minutes spent being sedentary as measured by an accelerometer.
Time frame: From baseline to follow-up (approximately 22 weeks).
Baseline to follow-up change in maximal oxygen utilization during physical activity as measured by VO2peak during an exercise stress test.
Jamie Jackson
Other
Acronym: CHD-PALS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04135859
Behavior, Cardiovascular Abnormalities
Columbus, Ohio, United States
View Trial DetailsNCT06003023
Behavior, Cardiovascular Abnormalities
Columbus, Ohio, United States
View Trial DetailsNCT06589336
Cardiovascular Disease Other, Stage 2 Cardiovascular-Kidney-Metabolic Syndrome
Columbus, Ohio, United States
View Trial DetailsNCT06774391
Amyloidosis, Arrhythmias, Cardiac
Bologna, Italy
View Trial Details